KPC Pharmaceuticals announced that its 1 billion yuan medium-term note registration application has been accepted by the National Association of Financial Market Institutional Investors. The registration quota is valid for two years from the date of the notice, with Industrial Bank, China Merchants Bank, and Bank of China serving as joint lead underwriters. The company may issue the notes in tranches during the registration validity period, and after each issuance is completed, it must disclose the issuance results through channels recognized by the association.
KPC Pharmaceuticals IncKPC Pharmaceuticals' 1 billion yuan medium-term note registration application was accepted, giving it a new debt-financing channel.
